KPIs & Operating Metrics(New)
Growth Metrics

Medtronic (MDT) Cash from Financing Activities (2016 - 2026)

Medtronic's Cash from Financing Activities history spans 13 years, with the latest figure at -$2.1 billion for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 19.05% to -$2.1 billion in Q1 2026 year-over-year; TTM through Jan 2026 was -$5.2 billion, a 3.18% increase, with the full-year FY2025 number at -$4.4 billion, up 2.0% from a year prior.
  • Cash from Financing Activities hit -$2.1 billion in Q1 2026 for Medtronic, down from -$395.0 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for MDT hit a ceiling of $3.0 billion in Q4 2022 and a floor of -$4.9 billion in Q2 2023.
  • Historically, Cash from Financing Activities has averaged -$1.2 billion across 5 years, with a median of -$1.3 billion in 2025.
  • Biggest five-year swings in Cash from Financing Activities: soared 360.95% in 2022 and later crashed 493.33% in 2024.
  • Tracing MDT's Cash from Financing Activities over 5 years: stood at $3.0 billion in 2022, then crashed by 102.99% to -$90.0 million in 2023, then crashed by 493.33% to -$534.0 million in 2024, then rose by 26.03% to -$395.0 million in 2025, then plummeted by 428.35% to -$2.1 billion in 2026.
  • Business Quant data shows Cash from Financing Activities for MDT at -$2.1 billion in Q1 2026, -$395.0 million in Q4 2025, and -$1.4 billion in Q3 2025.